These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 23673415

  • 1. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
    Morales MG, Cabrera D, Céspedes C, Vio CP, Vazquez Y, Brandan E, Cabello-Verrugio C.
    Cell Tissue Res; 2013 Jul; 353(1):173-87. PubMed ID: 23673415
    [Abstract] [Full Text] [Related]

  • 2. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
    Morales MG, Gutierrez J, Cabello-Verrugio C, Cabrera D, Lipson KE, Goldschmeding R, Brandan E.
    Hum Mol Genet; 2013 Dec 15; 22(24):4938-51. PubMed ID: 23904456
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.
    Morales MG, Vazquez Y, Acuña MJ, Rivera JC, Simon F, Salas JD, Alvarez Ruf J, Brandan E, Cabello-Verrugio C.
    Int J Biochem Cell Biol; 2012 Nov 15; 44(11):1993-2002. PubMed ID: 22964022
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle.
    Painemal P, Acuña MJ, Riquelme C, Brandan E, Cabello-Verrugio C.
    Biofactors; 2013 Nov 15; 39(4):467-75. PubMed ID: 23460581
    [Abstract] [Full Text] [Related]

  • 5. CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy.
    Morales MG, Cabello-Verrugio C, Santander C, Cabrera D, Goldschmeding R, Brandan E.
    J Pathol; 2011 Dec 15; 225(4):490-501. PubMed ID: 21826667
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles.
    Cabello-Verrugio C, Morales MG, Cabrera D, Vio CP, Brandan E.
    J Cell Mol Med; 2012 Apr 15; 16(4):752-64. PubMed ID: 21645240
    [Abstract] [Full Text] [Related]

  • 7. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
    Sun G, Haginoya K, Dai H, Chiba Y, Uematsu M, Hino-Fukuyo N, Onuma A, Iinuma K, Tsuchiya S.
    J Neurol Sci; 2009 May 15; 280(1-2):40-8. PubMed ID: 19232644
    [Abstract] [Full Text] [Related]

  • 8. Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling.
    Acuña MJ, Pessina P, Olguin H, Cabrera D, Vio CP, Bader M, Muñoz-Canoves P, Santos RA, Cabello-Verrugio C, Brandan E.
    Hum Mol Genet; 2014 Mar 01; 23(5):1237-49. PubMed ID: 24163134
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
    Cofre C, Acuña MJ, Contreras O, Morales MG, Riquelme C, Cabello-Verrugio C, Brandan E.
    Biofactors; 2015 Mar 01; 41(2):111-20. PubMed ID: 25809912
    [Abstract] [Full Text] [Related]

  • 10. Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice.
    Cozzoli A, Nico B, Sblendorio VT, Capogrosso RF, Dinardo MM, Longo V, Gagliardi S, Montagnani M, De Luca A.
    Pharmacol Res; 2011 Nov 01; 64(5):482-92. PubMed ID: 21689754
    [Abstract] [Full Text] [Related]

  • 11. Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis.
    Riquelme-Guzmán C, Contreras O, Brandan E.
    Am J Physiol Cell Physiol; 2018 Apr 01; 314(4):C415-C427. PubMed ID: 29351412
    [Abstract] [Full Text] [Related]

  • 12. Analysis of Pathological Activities of CCN2/CTGF in Muscle Dystrophy.
    Acuña MJ, Brandan E.
    Methods Mol Biol; 2017 Apr 01; 1489():513-521. PubMed ID: 27734402
    [Abstract] [Full Text] [Related]

  • 13. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.
    Farini A, Meregalli M, Belicchi M, Battistelli M, Parolini D, D'Antona G, Gavina M, Ottoboni L, Constantin G, Bottinelli R, Torrente Y.
    J Pathol; 2007 Oct 01; 213(2):229-38. PubMed ID: 17668421
    [Abstract] [Full Text] [Related]

  • 14. Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker.
    Taniguti AP, Pertille A, Matsumura CY, Santo Neto H, Marques MJ.
    Muscle Nerve; 2011 Jan 01; 43(1):82-7. PubMed ID: 21108244
    [Abstract] [Full Text] [Related]

  • 15. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
    Gibertini S, Zanotti S, Savadori P, Curcio M, Saredi S, Salerno F, Andreetta F, Bernasconi P, Mantegazza R, Mora M.
    Cell Tissue Res; 2014 May 01; 356(2):427-43. PubMed ID: 24723230
    [Abstract] [Full Text] [Related]

  • 16. Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.
    Iwamoto M, Hirohata S, Ogawa H, Ohtsuki T, Shinohata R, Miyoshi T, Hatipoglu FO, Kusachi S, Yamamoto K, Ninomiya Y.
    Hypertens Res; 2010 Dec 01; 33(12):1305-11. PubMed ID: 20944640
    [Abstract] [Full Text] [Related]

  • 17. A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice.
    De Luca A, Nico B, Liantonio A, Didonna MP, Fraysse B, Pierno S, Burdi R, Mangieri D, Rolland JF, Camerino C, Zallone A, Confalonieri P, Andreetta F, Arnoldi E, Courdier-Fruh I, Magyar JP, Frigeri A, Pisoni M, Svelto M, Conte Camerino D.
    Am J Pathol; 2005 Feb 01; 166(2):477-89. PubMed ID: 15681831
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
    Gu J, Liu X, Wang QX, Tan HW, Guo M, Jiang WF, Zhou L.
    Exp Cell Res; 2012 Oct 01; 318(16):2105-15. PubMed ID: 22749815
    [Abstract] [Full Text] [Related]

  • 19. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 01; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.